Investor Presentation Q4 2018
|
|
- Jewel McKenzie
- 5 years ago
- Views:
Transcription
1 Investor Presentation Q4 2018
2 2/22 Forward Looking Statement The information contained herein, together with any amendments or supplements and any other information that may be furnished by the company, includes forward-looking information. Such information is based on assumptions as to future events that are inherently uncertain and subjective. The company makes no representation or warranty as to the attainability of such assumptions, including the completion of a financing or as to whether future results will occur as projected. It must be recognized that the projections of the company s future performance are necessarily subject to a high degree of uncertainty, that actual results can be expected to vary from the results projected and that such variances may be material and adverse. Prospective investors are expected to conduct their own investigation with regard to the company and its prospects. This presentation does not constitute an offer to sell or a solicitation of an offer to buy any security.
3 3/22 01 SUMMARY Executive Summary 4 02 INVESTING IN CANNABIS Growing Demand for Medical Cannabis 6 Recreational Cannabis Market 7 Supply of Cannabis 8 Table of Contents 03 INDIVA ADVANTAGES Talented and Experienced Team 10 High Quality Products 11 Our Corporate Identity 14 Customer Acquisition Strategies LONDON FACILITY London Facility 17 Production Facility Pictures 19 Expansion Path - s, Oil, Products COST BREAKDOWN London Operating Expenses 22
4 4/22 NEAR TERM CATALYSTS Executive Summary Sales INDIVA received its sales license on August 10, 2018 and sales have begun. Expansion Cultivation and oil extraction: Fully funded expansion to 40,000 square feet underway and to be completed in Q4 of Processing Facility Fully funded processing facility planned for Facility to produce INDIVA, Bhang, DeepCell and other cannabis products. Capitalization: Basic Shares Outstanding mm Warrants: mm Options:...4.7mm Convert:...6.9mm Fully Diluted Shares Outstanding mm Balance Sheet: Cash (June 30, 2018)...$27.3mm Convertible Debenture...$5.1mm Management and Insider Ownership...22% STRONG FUNDAMENTALS Award-winning cannabis products State-of-the-art GMP-standard indoor production facility Fully funded expansion Experienced Master Grower with awardwinning strains and loyal patient base Experienced management team, passionate about helping people and protecting investors
5 Executive Summary Investing in Cannabis INDIVA Advantages London Facility Cost Breakdown Q Investing in Cannabis
6 6/22 Health Canada s Projected Registered Patients Actual Registered Patients Growing Demand for Medical Cannabis 16,599 physicians have authorized patient access to medicinal marijuana 330,758 registered patients in total to date ( ~ 80% from ON and AB) 10,000 (approx.) new patients per month Registered Patients 450, , , , , , , ,000 50, GROWTH RATE OF MEDICINAL CANNABIS USERS IS HIGHER THAN EXPECTED Health Canada projected 450,000 patients will be using cannabis at $1.3 billion annual revenue by ,000,000 5,000,000 4,000,000 3,000,000 2,000,000 1,000, Multiple Sclerosis Epilepsy Cancer Low BMI Severe Pain June 2018: registered patients exceeds Health Canada s 2023 projection 2019 Risk of Depression 2020 Migraine Headaches Insomnia 2021 Anxiety 2022 Arthritis 2023 Hypertension 2024 Life Stress (Elevated) POTENTIAL MARKET _ Source: Health Canada, Statistics Canada, Canadian Community Health Survey, medicalmarijuana.ca
7 7/22 Daily Weekly Monthly Occasionally Non-Consumers Potential Customer Recreational Cannabis 17% 61% 7% 4% 3% 8% SIZE AND MAKEUP OF THE CANADIAN RECREATIONAL MARKET According to the Deloitte Survey, the size of the Canadian recreational cannabis market could be as much as $8.7 billion per year, or similar to the size of the Canadian spirit market. $7-10 Billion Domestic Market Users (Thousands) Consumption (Metric Tonnes) Source: Deloitte, PBO Opportunity! * 2.6 million Canadians admit to use in last 12 months * Represents <5% of total consumption Once Less than once a month 1-3 Times per month At least once a week Daily ANNUAL CANNABIS USERS AND CONSUMPTION Aged 15 and over, Canada excluding Territories, Mid-point Estimates, 2018
8 8/22 Supply of Cannabis OVER-supply of dry flower just around the corner! Current Production 132 existing LPs Current production insufficient to meet demand 70 Sales Licenses issued YT 0 BC 30 NT 0 AB 9 SK 4 Source: Mackie Research, 420intel.com NU 0 MB 2 ON 69 Licensed Producer Production Capacity Tonnes Aurora Cannabis Canopy Growth Aphria Tilray The Green Organic Dutchman...95 Cronos Group OrganiGram HEXO CannTrust Emerald Health Therapeutics TOTAL (metric tonnes)...2,411 QC 12 NB 3 Number of licences issued by province NS 3 NL 0 PE 1
9 Executive Summary Investing in Cannabis INDIVA Advantages London Facility Cost Breakdown Q INDIVA Advantages
10 10/22 FINANCE & CORPORATE DEVELOPMENT Niel Marotta President & CEO, Director, Founder Managed over $1 Billion across several industries Involved in capital raises and M&A transactions exceeding $1 Billion CREATIVE Tom Borowicz Chief Brand Officer Over 30 years of experience in marketing, branding, print/digital advertising and design with Fortune 500 companies Talented & Experienced Team LEGAL & BUSINESS DEVELOPMENT Koby Smutylo COO, General Counsel, Director, Founder Koby is a seasoned lawyer and has acted as counsel to private and public companies Helped finance and license an ACMPR LP FINANCE Jennifer Welsh, CPA Chief Financial Officer Managed a global finance team for eight years as Corporate Controller of a TSX listed company Former consultant for a publicly traded LP PRODUCTION Pete Young Master Grower, Founder Grow Team: 15+ years of experience producing medicinal strains for hundreds of patients International recognition and multiple product awards PROJECT MANAGEMENT Jose Laurentino Chief Technology Officer 20+ years in agricultural project development including indoor and greenhouse expertise CORPORATE DEVELOPMENT Jamie Riff, P.Eng VP Corporate Development 15+ years experience in capital markets and institutional sales
11 11/22 INDIVA High Quality Products Our strain selection, cultivation and client care processes combine the know-how and experience of an internationally recognized and award winning grow-team with GMP-compliant quality assurance standard operating procedures. INDIVA is focused on providing medical-grade cannabis to medical and adult-use clients, both domestically and internationally.
12 12/22 Products Powered by INDIVA Bhang is the most awarded line of cannabis chocolate bars available in the world.
13 13/22 Products Powered by INDIVA Ruby sugars and salts are the world s first Flexible Edible cannabis product created to easily incorporate into your everyday food and drink.
14 14/22 Our Corporate Identity POSITIONING At INDIVA, we believe cannabis can add to one s general wellness and we stand for the destigmatization and normalization of cannabis for medicinal and recreational use. INDIVA is an experienced producer of high quality cannabis products designed to contribute to the health and wellness of its clients. Our logo symbolizes experience, strength, know-how practical knowledge, as well as a strong foundation for investment and growth. It is respectful of the cannabis movement without the clichés of cannabis counter-culture. Our clean aesthetic and pallet strike the perfect balance between mature yet accessible, contemporary but still classic enough to be lasting, and holistic without looking like products that only belong in a health food store. Our website and media content features contributors focused not just on cannabis, but wellness (nutrition, fitness, sleep) and culture (dining, events). Our associations with award winning American brands that we will produce and sell in Canada and internationally with our powered by INDIVA logo.
15 15/22 COMPASSION COMMUNITY RELATIONS Established relations with prominent and experienced members of the compassion community We will offer familiar strains and an overall respectful and familiar patient experience Agreement with London Compassion Society to transfer up to 1,200 clients Customer Acquisition Strategies We are for tweny. You buy. You help MARKETING SEO, E-shop, blog, and social media campaigns launched in 2017; mailing list of up to 2,000 clients Partnerships with popular social media influencers Packaging developed and focus group tested Engaging events team and keynotes at cannabis, wellness, cultural, and community events across Canada Featured interviews in key publications MEDICAL AND COMMUNITY ENGAGEMENT Strong ties to London s medical community Mandate to support patient networks and societies PROVINCIAL RETAIL STRATEGY Farm gate sales Sales teams active in multiple provinces Responding to provincial RFPs and retailers Access to award winning US products
16 Executive Summary Investing in Cannabis INDIVA Advantages London Facility Cost Breakdown Q London Facility
17 17/22 London Facility Cultivation Oil Extraction Processing Product Manufacturing Retail 40,000 square feet 30 Year Lease with right of first refusal to purchase Ample power & water 1 Kilometre from Highway 401 Extraction and processing facility under construction Retail store to be built on site
18 18/22 Indiva Store Oil Extraction and Processing Indiva Store Mother Room Oil Extraction Drying Room Trim Room London Facility Packaging Drying Room 2 Trim Room 2 Room Mother Room 2 Fully Funded Veg Veg Room $13.7 million Expansion Dry 2 Trim 2 Pack Pump Mother 2 Veg Storage/Receiving Pump Admin/Call Center/QA Admin Dry Trim Str/Rec Mother Planned Expansion ( Rooms) Existing Fenceline
19 19/22 Production Facility
20 20/22 Expansion Path s Oil Products Domestic Expansion International Expansion LARGE SCALE CULTIVATION / OFFTAKE Currently evaluating facilities in South Western Ontario for production partnerships INDIVA s criteria: newer glass houses, access to infrastructure, experienced production partner, ability to fund retrofit out of existing cash resources, measured expansion over time INTERNATIONAL DISTRIBUTION & PRODUCTION Active negotiations with German distributors for large quantity multi-year supply Exploring EU production partnership Agreements with US cannabis products companies to use Canada to produce and export internationally Active negotiations with Polish, Costa Rican and Maltese governments for production partnerships
21 Executive Summary Investing in Cannabis INDIVA Advantages London Facility Cost Breakdown Q Cost Breakdown
22 22/22 1. Power 7 2. Bulbs 1 3. Labour 4. Shipping 6 London Operating Expenses 5. Packaging 6. Materials 7. Contingency KEY EXPENSES Cash costs: Power, light bulbs, labour, packaging, shipping, soil & nutrients, composting, QA testing and contingency (20%) G&A: Management, accounting staff/admin, customer service/call center, security, distribution team Rent, insurance & security EMPLOYEES (ESTIMATED) Full production: 47 Senior management (5) Accounting (3) Gardening (10) Security/IT (2) Distribution (5) Customer Service (12) Sales (3) QA (2) Marketing (5) Software
23 For FAQs and contact information visit
Investor Presentation Q2 2018
Investor Presentation Q2 2018 2/24 Forward Looking Statement The information contained herein, together with any amendments or supplements and any other information that may be furnished by the company,
More informationExperience is growing
1 / 30 our Experience is growing investor Q4 presentation 2 / 30 Forward Looking Statement The information contained herein, together with any amendments or supplements and any other information that may
More informationOur Experience is Growing
1 / 30 Our Experience is Growing investor Q3 presentation 2 / 30 Forward Looking Statement The information contained herein, together with any amendments or supplements and any other information that may
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
More informationFor personal use only
October 29 th, 2018 RotoGro to Acquire 100% of Canadian Lawful Cannabis License RotoGro to acquire 100% of the issued share capital of Supra THC from Valens GroWorks Corp. ( CSE:VGW ) Supra THC holds a
More informationFor personal use only
13 February 2018 Creso reports strong progress with construction of its Canadian medicinal cannabis production facility in Nova Scotia Highlights: Site works at Creso s Canadian medicinal cannabis production
More informationCannabis Legalization August 22, Ministry of Attorney General Ministry of Finance
Cannabis Legalization August 22, 2018 Ministry of Attorney General Ministry of Finance Federal Cannabis Legalization and Regulation The federal Cannabis Act received Royal Assent on June 21, 2018 and will
More informationapplicable securities laws in Canada. Although the Company believes that the expectations and assumptions on which the forward-looking statements
INVESTOR OVERVIEW DISCLAIMER Certain information regarding The Supreme Cannabis Company, Inc. ( Supreme or the Company ) contained herein may constitute forward-looking statements within the meaning of
More informationVALENS GROWORKS COMPANY PROFILE CSE ticker: VGW
VALENS GROWORKS COMPANY PROFILE CSE ticker: VGW VALENS GROWORKS A multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes. We bring
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationCanopy Growth Corporation
Canopy Growth Corporation Contents Canopy Growth Corporation: Overview A Brief History of Cannabis Legal History of Cannabis in Canada Medical Cannabis Recreational Cannabis Provincial Distribution The
More informationCOMPANY PROFILE. CSE ticker: GW
COMPANY PROFILE CSE ticker: GW VALENS GROWORKS A multi-licensed, vertically integrated provider of cannabis products and services with a focus on proprietary extraction processes. We bring pure, high quality
More informationE N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE
I N V E S T O R P R E S E N TAT I O N Q 4 2 0 1 6 TM HEALTH THERAPEUTICS E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE T S X. V: E M H DISCLAIMER THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE
More informationLegal Licensing and Compliance in the Commercial Cannabis Industry
Legal Licensing and Compliance in the Commercial Cannabis Industry Legal Licensing and Compliance in the Cannabis Industry Local Approvals - City and County Regulations Filing your Cannabis License Affiliated
More informationINVESTOR DECK. February 2017
INVESTOR DECK February 2017 DISCLAIMER This document contains certain forward-looking statements and forward-looking information including but not limited to such statements relating to: the Company s
More informationTrip Report February 26, 2019
Trip Report February 26, 2019 February 19, 2019 Miami, Florida FLORIDA CANNABIS DISPENSARY TOUR PURPOSE OF THE TOUR The purpose of the trip was to assess the dispensary landscape in Florida and to see
More informationLetter to Shareholders
Letter to Shareholders February 2019 Dear Fellow Shareholders: As Co-Founder and Chief Executive Officer of Medicine Man Technologies, Inc. (OTCQX: MDCL), I want to thank you for being a shareholder in
More informationCanadian Marijuana Industry Snapshot: 17 Charts
Canadian Marijuana Industry Snapshot: 17 Charts Welcome to the first edition of the Canadian Marijuana Industry & Market Snapshot Report, produced by the research team at Marijuana Business Daily. In many
More informationLeading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF
Leading Cannabinoid Patient Care in Canada Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF Forward Looking Statements Except for historical information, this presentation contains forward-looking
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationCannabis Regulation in Canada:
Cannabis Regulation in Canada: Where We Came From, Where We Are and What s Coming Next Jonathan Sherman Cassels Brock & Blackwell LLP Sherri Altshuler Aird & Berlis LLP Canada, In Brief Right Now... Legal
More informationModel. Medical Access to Marihuana first established on a case by case basis using exemptions
Table 1: Legal Framework for Cannabis in Canada Legal Framework Section 56 Exemptions under Controlled Drugs and Substances Act (1999) Marihauna Medical Access Regulations (MMAR) 2001 Marihuana for Medical
More informationSPECIALTY MEDICAL CANNABIS COMPANY
SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward
More informationCheers! Why the Future of Cannabis is in Beverages. TSXV:BEER
Cheers! Why the Future of Cannabis is in Beverages TSXV:BEER www.hillstreetbeverages.com Forward Looking Statements, blah, blah, blah This Presentation may contain statements which constitute forward-looking
More informationRecent trends in medical cannabis use in Canada
Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationwhich has been used to help the treatment of epilepsy, seizures, alleviate neuropathic pain and muscular dystrophy.
News Release April 10, 2018, Kelowna, BC Marapharm Ventures Inc. To Introduce Organic CBD Health and Wellness Products To Be Featured In Its California Dispensary Marapharm Ventures Inc. (CSE: MDM) (OTCQX:
More informationDelivering high quality, cost effective cannabinoid medicines to patients (ASX:AC8) September 2018
Delivering high quality, cost effective cannabinoid medicines to patients (ASX:AC8) September 2018 Disclaimer This presentation has been prepared by AusCann Group Holdings Ltd ACN 008 095 207 ( Company
More informationInvestor Presentation
Investor Presentation Spring 2019 OTCQX:MDCL www.medicinemantechnologies.com SAFE HARBOR STATEMENT: This presentation may contain forward looking statements which are based on current expectations, forecasts,
More informationCannabis Law. June 29, 2018
HIGHLIGHTS OF THE NEW CANNABIS REGULATIONS ENACTED UNDER THE CANNABIS ACT By Rick Moscone and Russell Sanders On June 21, 2018, the Cannabis Act (the "Act") received Royal Assent, marking a historic milestone
More informationALLIANCE GROWERS. Investor Presentation Chilco Design Studio Inc.
ALLIANCE GROWERS Investor Presentation 2018 2018 Chilco Design Studio Inc. Forward-Looking Statements Disclaimer Certain information regarding the company contained herein may constitute forward-looking
More informationJames Donaldson CEO and Executive Director
Welcome! James Donaldson CEO and Executive Director Dr. Natasha Ryz Chief Science Officer, Zenabis Cannabis 101 Introduction to Cannabis Plant Cannabis is a genus of flowering plants within the family
More informationJTI Switzerland. JTI Schweiz 3
JTI Schweiz 3 Who we are 300 employees JTI has been manufacturing tobacco products in the Wiggertal area for over 45 years. The local market organization and the production facility in Dagmersellen (canton
More informationA COMMITTEE OF THE WHOLE MEETING WILL BE HELD IN THE MUNICIPAL COUNCIL CHAMBERS AT CITY HALL ON THURSDAY, NOVEMBER 16, 2017 AT 12:00 P.M.
A COMMITTEE OF THE WHOLE MEETING WILL BE HELD IN THE MUNICIPAL COUNCIL CHAMBERS AT CITY HALL ON THURSDAY, NOVEMBER 16, 2017 AT 12:00 P.M. A G E N D A A. COMMITTEE OF THE WHOLE 1. Danielle Myles, Economic
More informationCEOCFO Magazine. Chris Wagner Chief Executive Officer. Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF)
CEOCFO Magazine ceocfointerviews.com All rights reserved Issue: March 19, 2018 Q&A with Chris Wagner, CEO of Emerald Health Therapeutics, Inc. a Health Canada Licensed Producer of Medical Cannabis allowing
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationSUBJECT: Cannabis legislation and implications for the City of Burlington
Page 1 of Report CM-11-17 SUBJECT: Cannabis legislation and implications for the City of Burlington TO: FROM: Committee of the Whole City Manager's Office Report Number: CM-11-17 Wards Affected: All File
More informationInvestor Presentation May 2, 2017
CSE: TBP OTC: GRPOF Investor Presentation May 2, 2017 Forward Looking Statements This presentation contains certain forward-looking statements that may involve a number of risks and uncertainties. Actual
More informationThe federal legislation, Cannabis Act that legalizes recreational cannabis comes into effect on October 17, 2018.
City of Mississauga Q&A What is cannabis? Cannabis or Marijuana is commonly used to refer to parts of a cannabis plant, such as the leaves or flowers. Cannabis is used in many ways including smoking, vaporizing,
More informationPROACTIVE INVESTOR PRESENTATION
www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,
More informationHealthy People, Healthy Communities
Healthy People, Healthy Communities Public Health Policy Statements on Public Health Issues The provincial government plays an important role in shaping policies that impact both individual and community
More information2018 OAAS CONVENTION. Fair s and Marijuana. Shawn LaPalm
2018 OAAS CONVENTION Fair s and Marijuana Shawn LaPalm The information provided here after was up to date as per the presentation date. Due to ever evolving legislative changes at the Federal, Provincial
More informationTOBACCO INDUSTRY MONITORING TOOL
TOBACCO INDUSTRY MONITORING TOOL CTCA MakSPH 1 Centre for Tobacco Control in Africa (CTCA) Library Cataloguing - in Publication Data Supporting African governments to build and sustain capacity for tobacco
More informationAMERICAN ROOTS. GLOBAL REACH CSE: TGIF FWB: 1QF OTC: TGIFF
AMERICAN ROOTS. GLOBAL REACH 1 Friday Night Inc. is focused on strengthening and expanding its current cannabis operations and consultancy, and is positioning itself to thrive in the rapidly evolving cannabis
More informationRULES OF CONDUCT OF INSIDERS RESPECTING
T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )
More informationCanadian National Medical Marijuana Association (CNMMA)
Canadian National Medical Marijuana Association (CNMMA) Our Mission Is to ensure all Canadian patients who benefit from medical marijuana, have access to the highest quality of product and services, to
More informationMedicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu
Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, 2017 Kamau Chionesu kamau.chionesu02@uwimona.edu.jm Questions 1. What are the likely key requirements for successful participation
More informationSPECIALTY MEDICAL CANNABIS COMPANY
SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward
More informationTHE DRINKS MARKET PERFORMANCE. Prepared for the Drinks Industry Group of Ireland By Anthony Foley Dublin City University Business School
THE DRINKS MARKET PERFORMANCE 2017 Prepared for the Drinks Industry Group of Ireland By Anthony Foley Dublin City University Business School Foreword by DIGI The Drinks Industry Group of Ireland (DIGI)
More informationFor personal use only
AusCann Makes Major Progress Towards Production of Cannabinoid Medicines During FY18 Highlights Undertook comprehensive pharmaceutical development project to create an optimal dosage form cannabinoid medicine
More informationNevada s Marijuana Roots
RIANA DURRETT INTRODUCTION Practiced law for 5 years Nevada Dispensary Association Non-profit 501(c)(6) Corporation, formed in 2014 to develop and promote best practices in marijuana industry. Represents
More informationResponsible Retailing of Recreational Cannabis. Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat
Responsible Retailing of Recreational Cannabis Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat Introduction On behalf of British Columbia s Alliance of Beverage Licensees
More informationBackground. Recommendation 1
TABLED DOCUMENT 222-18(3) TABLED ON OCTOBER 11, 2018 GOVERNMENT OF THE NORTHWEST TERRITORIES RESPONSE TO COMMITTEE REPORT 7-18(3): REPORT ON THE REVIEW OF BILL 6: CANNABIS LEGALIZATION AND REGULATION IMPLEMENTATION
More informationThe Opportunity CANADIAN GROWING FACILITIES AUSTRALIAN GROWING FACILITIES CBD PRODUCT AND BRAND DEVELOPMENT
EXECUTIVE SUMMARY 2018 The Opportunity CANADIAN GROWING FACILITIES MYM has two production projects. both in Quebec - Laval and Weedon. Laval - Facility is currently under construction and is expected to
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationLegalization of Recreational Cannabis
Legalization of Recreational Cannabis Private Recreational Cannabis Retail Storefronts December 11, 2018 History of Cannabis Legalization April 13, 2017 Federal Bill C-45, otherwise known as the Cannabis
More informationFrequently Asked Questions
Frequently Asked Questions The Halton Regional Police Service, in collaboration with the Region of Halton Health Department, has created a collection of Frequently Asked Questions (FAQ) regarding how Bill
More informationB.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations
B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British
More informationInclusion of Craft Cannabis: Protecting BC s Economy
BC Cannabis Regulation Engagement Submission Paper Inclusion of Craft Cannabis: Protecting BC s Economy October 31, 2017 Prepared by Sarah Campbell, David Robinson and Teresa Taylor for the Craft Cannabis
More informationPLANNING IMPLICATIONS FOR CANNABIS LEGISLATION. Zone 7 & 8 Spring Workshop April 19, 2018
PLANNING IMPLICATIONS FOR CANNABIS LEGISLATION Zone 7 & 8 Spring Workshop April 19, 2018 Legislative History Legislative History Legislative History Current Status Cannabis currently only permitted for
More informationUPDATED: Alberta's Cannabis Retail Regulations and City of Calgary Land Use Bylaw Amendments
UPDATED: Alberta's Cannabis Retail Regulations and City of Calgary Land Use Bylaw Amendments Daryl Fridhandler, Q.C. and Emily McDermott Introduction On February 16, 2018 the Alberta government released
More informationRetail Cannabis Public Information Centre December 12, Paul Voorn, Associate Solicitor Ted Horton, Planner
Retail Cannabis Public Information Centre December 12, 2018 Paul Voorn, Associate Solicitor Ted Horton, Planner Overview Introduction Legal context Federal & Provincial law Places of consumption Responsibilities
More informationCannabis Culture Poll. November 2018
Cannabis Culture Poll November 2018 About the poll The 2018 Fall Cannabis Culture Poll explores attitudes and views on cannabis to better understand the lifestyle of modern cannabis consumers and the future
More informationRecommendations to Spokane Clean Air Agency
CANNABIS FARMERS COUNCIL Recommendations to Spokane Clean Air Agency Crystal Oliver 5/23/2016 Recommendations to the Spokane Clean Air Agency regarding prevention & minimizing of offsite marijuana odors
More informationThe Opportunity CANADIAN GROWING FACILITIES AUSTRALIAN GROWING FACILITIES CBD PRODUCT AND BRAND DEVELOPMENT
EXECUTIVE SUMMARY 2017 The Opportunity CANADIAN GROWING FACILITIES MYM has two production projects. both in Quebec - Laval and Weedon. Laval - Facility is currently under construction and is expected to
More informationCannabis Legalization in Alberta
Cannabis Legalization in Alberta Regulation and Supply Chain Roundtable #3 Discussion Topics Potential for cannabis cafes or lounges Public education priorities Potential for economic development Alberta
More informationLegalization of Recreational Cannabis. Mary Ellen Bench City Solicitor, City of Mississauga November 26, 2018
Legalization of Recreational Cannabis Mary Ellen Bench City Solicitor, City of Mississauga November 26, 2018 October 17, 2018 recreational cannabis legalized (Canada) Ontario allows on-line purchases April
More informationCOMPANY PRESENTATION JULY Bob Bechard Executive Vice-President Corporate Development & Licensing
COMPANY PRESENTATION JULY 2018 Bob Bechard Executive Vice-President Corporate Development & Licensing Forward Looking Statements Some statements in this release may contain forward-looking information.
More informationCITY OF BROOKS BYLAW NO. 18/19
CITY OF BROOKS BYLAW NO. 18/19 A BYLAW OF THE CITY OF BROOKS IN THE PROVINCE OF ALBERTA TO AMEND BYLAW NO. 14/12, BEING THE LAND USE BYLAW TO INTRODUCE PERSONAL CANNABIS CULTIVATION, RETAIL CANNABIS STORES,
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationCannabis Retail Store Licensing in Ontario. General Committee December 10, 2018
1 Cannabis Retail Store Licensing in Ontario General Committee December 10, 2018 Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Presentation Outline Federal Regulatory
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationPARTNERSHIP & SPONSORSHIP OPPORTUNITIES
PARTNERSHIP & SPONSORSHIP OPPORTUNITIES About MPI Meeting Professionals International (MPI) is the largest meeting and event industry association worldwide. Founded in 1972, the organization provides innovative
More informationRECREATIONAL CANNABIS. Province of British Columbia regulations
RECREATIONAL CANNABIS Province of British Columbia regulations SUMMARY/BACKGROUND On April 13, 2017, the Government of Canada introduced Bill C-45, an Act respecting cannabis and to amend the Controlled
More informationInvestor Presentation June 2012 NASDAQ: CEMI
Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act
More informationPresented by: GEORGE SCORSIS CEO
Presented by: GEORGE SCORSIS CEO CSE: LHS OTCBB: LHSIF Who We Are Liberty is one of twelve licensed producers and sellers of medical cannabis in Florida. Liberty prioritizes investment in states that meet
More informationHigher Ground. Insights from Canada s Most Comprehensive Consumer Cannabis Study. Pat A. Pellegrini, Ph.D. President and CEO Vividata
Higher Ground Insights from Canada s Most Comprehensive Consumer Cannabis Study Pat A. Pellegrini, Ph.D. President and CEO Vividata pat@vividata.ca National Headlines Shopify plots online cannabis-sales
More informationCannabis 101: Industry landscape and the road to edibles. Presented by: Glenn Fraser Date: May 10, 2018
Cannabis 101: Industry landscape and the road to edibles Presented by: Glenn Fraser Date: May 10, 2018 CANADA & GLOBAL DOMINANCE Global cannabis landscape Global cannabis consumption The U.S. roadmap Canadian
More informationTotal Face Group Limited
Total Face Group Limited 2017 Half Year Results Presentation Contents Results Highlights Highlights Half Year Results Revenue Bridge Revenue Breakdown Clinic Profitability Profit & Loss Financial Position
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationREGIONAL DISTRICT OF CENTRAL KOOTENAY Committee Report
REGIONAL DISTRICT OF CENTRAL KOOTENAY Committee Report Date of Report: March 1, 2018 Date & Type of Meeting: March 14, 2018 Rural Affairs Committee Author: Meeri Durand, Planning Manager Subject: CANNABIS
More informationCANNABIS IN YOUR COMMUNITY. A Presentation to CPAA Conference May 2017
CANNABIS IN YOUR COMMUNITY A Presentation to CPAA Conference May 2017 WE LL BE THERE FOR YOUR HIGHS AND LOWS! Presented by: MUNICIPAL Charlotte A. St. Dennis Senior Associate Edmonton Office cstdennis@brownleelaw.com
More informationTransitioning Canada s Cannabis Industry
Submission of the Canadian Association of Medical Cannabis Dispensaries to the Standing Committee on Health, August 2017 Attention: Mr. Bill Casey, MP Chair, House of Commons Standing Committee on Health
More informationCorporate Development Committee Report
To: From: Corporate Development Committee Report To the Chair and Members of the Corporate Development Committee Jyoti V. Zuidema, Solicitor and Corporate Counsel Date: December 7, 2018 Subject: CD-18-98,
More informationUpdate on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council
Update on the Legalization and Regulation of Cannabis January 8, 2018 Regular Meeting of Delta Council Regulatory Authority for Cannabis Federal authority: Cultivation & Manufacturing Licensing, inspection,
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More informationAgracan - LP. Palmerston Industrial Park Cannabis Cultivation Facility
Agracan - LP Palmerston Industrial Park Cannabis Cultivation Facility Legislative Background Legal access to dried marijuana for medical purposes was first provided in 1999. In 2000 individuals with a
More informationIABC Newfoundland and Labrador Chapter Management Awards 2018 Event Management INTRODUCTION
INTRODUCTION Our small chapter of International Association of Business Communicators is located in Newfoundland and Labrador a Canadian island in the North Atlantic and inspiration for the award winning
More informationLet s Toke Business. By Ted Ohashi
Let s Toke Business Week Ended April 7, 2017 By Ted Ohashi Canadian marijuana stocks continue to advance as expected... p1 Major cannabis study provides basis for medical marijuana benefits... p2 OGI voluntary
More informationPermitted Cannabis Marketing Activities
CMAadvocacy.ca CMA Guide: Permitted Cannabis Marketing Activities This document provides general information. It does not constitute legal advice. Those with specific questions about the legislation and
More informationCannabis Legalization
Cannabis Legalization............................... An Update for Manitoba s Municipalities Michael Legary Priorities and Planning Secretariat Manitoba Finance April 12, 2018 REVIEW: Manitoba s Cannabis
More informationSAKURA 3 Open-Label Phase 3 Safety Study with DaxibotulinumtoxinA for Injection (RT002) for the Treatment of Moderate to Severe Glabellar Lines
SAKURA 3 Open-Label Phase 3 Safety Study with DaxibotulinumtoxinA for Injection (RT002) for the Treatment of Moderate to Severe Glabellar Lines Presented by Dan Browne, Co-Founder, President & CEO, and
More informationInvestor Presentation
Investor Presentation 26 June 2018 2018 MMJ PhytoTech Limited ASX: MMJ www.mmjphytotech.com.au MMJ Global cannabis investment company Listed on the ASX with the code MMJ Owns a portfolio of minority interests
More informationInvestor Presentation
Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More informationChina Silymarin Industry Overview,
China Silymarin Industry Overview, 2017-2021 China Silymarin Industry Overview, 2017-2021 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationUnderstanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More information